Adeptus Biotechnologies Corp. (ADPT) PT Raised to $11 at BofA Securities
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $24.74 --0%
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 17
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 17
Join SI Premium – FREE
BofA Securities analyst Derik de Bruin raised the price target on Adeptus Biotechnologies Corp. (NASDAQ: ADPT) to $11.00 (from $10.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Upgrades Lonking Holdings Limited (3339:HK) (LONKF) to Buy
- Entain PLC (ENT:LN) (GMVHF) PT Lowered to GBP9.14 at Deutsche Bank
- LG Electronics India (LGEL:IN) PT Raised to INR1,885 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Derik de BruinSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
